{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:49:39Z","timestamp":1794667779513,"version":"4.9.1"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF1204900"],"award-info":[{"award-number":["2023YFF1204900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF1204901"],"award-info":[{"award-number":["2023YFF1204901"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFTD0026"],"award-info":[{"award-number":["2024NSFTD0026"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073698"],"award-info":[{"award-number":["82073698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122065"],"award-info":[{"award-number":["82122065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473845"],"award-info":[{"award-number":["82473845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFH0027"],"award-info":[{"award-number":["2022YFH0027"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025YFHZ0085"],"award-info":[{"award-number":["2025YFHZ0085"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research Foundation of Sichuan University","award":["2023SCUH0073"],"award-info":[{"award-number":["2023SCUH0073"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gram-negative bacterial resistance to \u03b2-lactam antibiotics is a growing clinical problem, largely driven by the production of metallo-\u03b2-lactamases (MBLs) and serine-\u03b2-lactamases (SBLs). Developing dual inhibitors targeting both MBLs and SBLs has emerged as a focus in the fight against \u03b2-lactam resistance. We previously identified the bicyclic oxo-boronate CB1 as a dual MBL\/SBL inhibitor through molecular generation based on the binding mode of carbapenem tetrahedral intermediates. Herein, we report the structural optimization of CB1, yielding new bicyclic oxo-boronates with potent dual MBL\/SBL inhibition, some of which could potentiate Meropenem efficacy against carbapenem-resistant Gram-negative superbugs. X-ray crystallography revealed a common binding mode of bicyclic oxo-boronates with VIM-2\/NDM-1 MBL and OXA-48 SBL, mimicking the binding of carbapenem intermediates. YL6113 exhibited pharmacokinetic characteristics similar to Meropenem and manifested efficacy when combined with Meropenem in a murine sepsis model. This work provides the basis for developing oxo-boronate-based inhibitors targeting MBLs\/SBLs and other relevant targets.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02230","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:17:23Z","timestamp":1760379443000},"page":"21807-21828","source":"Crossref","is-referenced-by-count":5,"title":["Structural\nOptimization of Bicyclic Oxo-Boronates\nas Dual Metallo- and Serine-\u03b2-Lactamase Inhibitors"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4173-1937","authenticated-orcid":true,"given":"Zeng-Bao","family":"Yang","sequence":"first","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2372-7478","authenticated-orcid":true,"given":"Si-Qi","family":"Wei","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8569-8432","authenticated-orcid":true,"given":"Yao-Geng","family":"Wang","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Min","family":"Dong","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7642-7725","authenticated-orcid":true,"given":"Hao-Xiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6507-1689","authenticated-orcid":true,"given":"Xiao-Lan","family":"Li","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Peng","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Chuan","family":"Yin","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4915-6677","authenticated-orcid":true,"given":"Guo-Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , , ,","place":["Chengdu, Sichuan, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2026072715535552800_cit1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between beta-lactamases and new beta-lactamase\ninhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat. Rev. Microbiol"},{"key":"2026072715535552800_cit2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/acsinfecdis.7b00243","article-title":"Game changers:\nnew \u03b2-lactamase inhibitor combinations targeting antibiotic\nresistance in Gram-negative bacteria","volume":"4","author":"Bush","year":"2018","journal-title":"ACS Infect.\nDis"},{"key":"2026072715535552800_cit3","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.3390\/ijms24065777","article-title":"Antibiotics and Bacterial Resistance-A\nShort Story of an Endless Arms Race","volume":"24","author":"Baran","year":"2023","journal-title":"Int. J.\nMol. Sci"},{"key":"2026072715535552800_cit4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01076-18","article-title":"Past and Present\nPerspectives on \u03b2-Lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob.\nAgents Chemother"},{"key":"2026072715535552800_cit5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of \u03b2-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit6","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-Lactamases and \u03b2-Lactamase\nInhibitors in the 21st Century","volume":"431","author":"Tooke","year":"2019","journal-title":"J. Mol. Biol"},{"key":"2026072715535552800_cit7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.tim.2023.01.013","article-title":"Metallo-\u03b2-lactamase-mediated\nantimicrobial resistance and progress\nin inhibitor discovery","volume":"31","author":"Yang","year":"2023","journal-title":"Trends Microbiol"},{"key":"2026072715535552800_cit8","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/med.21665","article-title":"Principles\nand current strategies targeting metallo-\u03b2-lactamase\nmediated antibacterial resistance","volume":"40","author":"Yan","year":"2020","journal-title":"Med. Res.\nRev"},{"key":"2026072715535552800_cit9","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.1021\/acs.chemrev.1c00138","article-title":"Metallo-\u03b2-lactamases in the\nAge of Multidrug Resistance: From Structure and Mechanism to Evolution,\nDissemination, and Inhibitor Design","volume":"121","author":"Bahr","year":"2021","journal-title":"Chem. Rev"},{"key":"2026072715535552800_cit10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic Acid: a\nBeta-Lactamase-Inhibiting Beta-Lactam from Streptomyces\nclavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/AAC.14.3.414","article-title":"CP-45,899,\na Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum\nof Beta-Lactams: Initial Bacteriological Characterization","volume":"14","author":"English","year":"1978","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02409-16","article-title":"Antimicrobial\nActivity of High-Proportion Cefepime-Tazobactam (WCK 4282) against\na Large Number of Gram-Negative Isolates Collected Worldwide in 2014","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding\nthe longevity of the beta-lactam antibiotics and of antibiotic\/beta-lactamase\ninhibitor combinations","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem. Pharmacol"},{"key":"2026072715535552800_cit14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4155\/fmc-2016-0078","article-title":"The road\nto avibactam: the first clinically useful non-\u03b2-lactam working\nsomewhat like a \u03b2-lactam","volume":"8","author":"Wang","year":"2016","journal-title":"Future Med.\nChem"},{"key":"2026072715535552800_cit15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jac\/dkh358","article-title":"In vitro activity of AVE1330A, an innovative broad-spectrum\nnon-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"54","author":"Bonnefoy","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"2026072715535552800_cit16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bmcl.2013.12.101","article-title":"Discovery of MK-7655, a \u03b2-lactamase inhibitor\nfor combination with Primaxin","volume":"24","author":"Blizzard","year":"2014","journal-title":"Bioorg. Med.\nChem. Lett"},{"key":"2026072715535552800_cit17","doi-asserted-by":"publisher","first-page":"709974","DOI":"10.3389\/fmicb.2021.709974","article-title":"Durlobactam, a New Diazabicyclooctane beta-Lactamase\nInhibitor for the Treatment of Acinetobacter Infections in Combination\nWith Sulbactam","volume":"12","author":"Shapiro","year":"2021","journal-title":"Front. Microbiol"},{"key":"2026072715535552800_cit18","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent,\nreversible, non-beta-lactam beta-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"2026072715535552800_cit19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.mib.2011.07.026","article-title":"Diazabicyclooctanes\n(DBOs): a potent new class of non-\u03b2-lactam \u03b2-lactamase\ninhibitors","volume":"14","author":"Coleman","year":"2011","journal-title":"Curr. Opin. Microbiol"},{"key":"2026072715535552800_cit20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02203-19","article-title":"Comparison of Treatment\nOutcomes between Analysis\nPopulations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam\nversus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible\nBacterial Infections","volume":"64","author":"Kaye","year":"2020","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit21","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1128\/AAC.00897-16","article-title":"Interaction of Avibactam with Class\nB Metallo-\u03b2-Lactamases","volume":"60","author":"Abboud","year":"2016","journal-title":"Antimicrob. Agents\nChemother"},{"key":"2026072715535552800_cit22","doi-asserted-by":"publisher","first-page":"2000246","DOI":"10.1002\/adtp.202000246","article-title":"Bicyclic Boronate \u03b2-Lactamase\nInhibitors: The Present Hope against Deadly Bacterial Pathogens","volume":"4","author":"Lence","year":"2021","journal-title":"Adv. Ther."},{"key":"2026072715535552800_cit23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02260-16","article-title":"Cyclic Boronates Inhibit All Classes of\n\u03b2-Lactamases","volume":"61","author":"Cahill","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit24","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.1021\/acs.jmedchem.9b00911","article-title":"Bicyclic Boronate VNRX-5133 Inhibits\nMetallo- and Serine-\u03b2-Lactamases","volume":"62","author":"Krajnc","year":"2019","journal-title":"J. Med.\nChem"},{"key":"2026072715535552800_cit25","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.1038\/ncomms12406","article-title":"Structural\nbasis of metallo-\u03b2-lactamase, serine-\u03b2-lactamase and penicillin-binding\nprotein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat.\nCommun"},{"key":"2026072715535552800_cit26","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1021\/acs.jmedchem.9b00735","article-title":"Structure-Based\nDevelopment of (1-(3\u2032-Mercaptopropanamido)methyl)boronic\nAcid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and\nSerine-\u03b2-lactamases","volume":"62","author":"Wang","year":"2019","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit27","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1039\/D1CC03026D","article-title":"Design and enantioselective synthesis of 3-(\u03b1-acrylic acid)\nbenzoxaboroles to combat carbapenemase resistance","volume":"57","author":"Xiao","year":"2021","journal-title":"Chem. Commun"},{"key":"2026072715535552800_cit28","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a Cyclic Boronic Acid beta-Lactamase Inhibitor\n(RPX7009) with Utility vs Class A Serine Carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit29","doi-asserted-by":"publisher","first-page":"17523","DOI":"10.1021\/acs.jmedchem.1c01722","article-title":"Selection\nof QPX7831, an Orally Bioavailable Prodrug of Boronic Acid beta-Lactamase\nInhibitor QPX7728","volume":"64","author":"Reddy","year":"2021","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit30","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1021\/acs.jmedchem.1c00437","article-title":"Discovery\nof VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable beta-Lactamase\nInhibitor for Enterobacterales Expressing Ambler Class A, C, and D\nEnzymes","volume":"64","author":"Trout","year":"2021","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit31","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1021\/acs.jmedchem.9b01518","article-title":"Discovery\nof Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-\u03b2-lactamase\nInhibitor for Carbapenem-Resistant Bacterial Infections","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit32","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery\nof Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of\nSerine and Metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J. Med.\nChem"},{"key":"2026072715535552800_cit33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (Taniborbactam),\na Broad-Spectrum Inhibitor of Serine- and Metallo-\u03b2-Lactamases,\nRestores Activity of Cefepime in Enterobacterales and Pseudomonas\naeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit34","doi-asserted-by":"publisher","first-page":"697180","DOI":"10.3389\/fmicb.2021.697180","article-title":"QPX7728, An\nUltra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral\nTherapy: Overview of Biochemical and Microbiological Characteristics","volume":"12","author":"Lomovskaya","year":"2021","journal-title":"Front. Microbiol"},{"key":"2026072715535552800_cit35","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s43588-025-00850-5","article-title":"Pharmacophore-oriented\n3D molecular generation toward efficient feature-customized drug discovery","volume":"5","author":"Peng","year":"2025","journal-title":"Nat. Comput. Sci"},{"key":"2026072715535552800_cit36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive\ncompound accumulation\nrules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"2026072715535552800_cit37","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/s41467-017-02339-w","article-title":"The mechanism\nof NDM-1-catalyzed carbapenem hydrolysis is distinct from that of\npenicillin or cephalosporin hydrolysis","volume":"8","author":"Feng","year":"2017","journal-title":"Nat.\nCommun"},{"key":"2026072715535552800_cit38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01202-19","article-title":"Structural\nInsights into the Mechanism of Carbapenemase Activity of the OXA-48\n\u03b2-Lactamase","volume":"63","author":"Smith","year":"2019","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026072715535552800_cit39","doi-asserted-by":"publisher","first-page":"13746","DOI":"10.1021\/acs.jmedchem.3c01189","article-title":"Discovery\nof 2-Aminothiazole-4-carboxylic Acids as Broad-Spectrum Metallo-\u03b2-lactamase\nInhibitors by Mimicking Carbapenem Hydrolysate Binding","volume":"66","author":"Yan","year":"2023","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit40","doi-asserted-by":"publisher","first-page":"105166","DOI":"10.1016\/j.ejps.2019.105166","article-title":"Enabling design\nof screening libraries for antibiotic discovery by modeling ChEMBL\ndata","volume":"143","author":"Sarkar","year":"2020","journal-title":"Eur. J. Pharm. Sci"},{"key":"2026072715535552800_cit41","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug\ndiscovery platform spanning multiple bioactivity data types and time\nperiods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026072715535552800_cit42","doi-asserted-by":"publisher","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","article-title":"BindingDB\nin 2024: a FAIR knowledgebase\nof protein-small molecule binding data","volume":"53","author":"Liu","year":"2025","journal-title":"Nucleic\nAcids Res"},{"key":"2026072715535552800_cit43","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/bioinformatics\/btab080","article-title":"Generating property-matched decoy\nmolecules using deep learning","volume":"37","author":"Imrie","year":"2021","journal-title":"Bioinformatics"},{"key":"2026072715535552800_cit44","doi-asserted-by":"publisher","first-page":"113965","DOI":"10.1016\/j.ejmech.2021.113965","article-title":"Structure-guided\noptimization of 1H-imidazole-2-carboxylic acid derivatives affording\npotent VIM-Type metallo-\u03b2-lactamase inhibitors","volume":"228","author":"Yan","year":"2022","journal-title":"Eur. J. Med. Chem"},{"key":"2026072715535552800_cit45","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1021\/jm400769b","article-title":"Assay platform for clinically relevant\nmetallo-\u03b2-lactamases","volume":"56","author":"van Berkel","year":"2013","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit46","doi-asserted-by":"publisher","first-page":"115473","DOI":"10.1016\/j.ejmech.2023.115473","article-title":"Metal binding\npharmacophore click-derived discovery\nof new broad-spectrum metallo-\u03b2-lactamase inhibitors","volume":"257","author":"Yan","year":"2023","journal-title":"Eur. J. Med. Chem"},{"key":"2026072715535552800_cit47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1107\/S1600576724002188","article-title":"Upgrade of crystallography\nbeamline BL19U1 at the Shanghai Synchrotron Radiation Facility","volume":"57","author":"Xiao","year":"2024","journal-title":"J. Appl. Crystallogr"},{"key":"2026072715535552800_cit48","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ejmech.2018.01.032","article-title":"((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives\nas metallo-\u03b2-lactamase inhibitors: Synthesis, kinetic and crystallographic\nstudies","volume":"145","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem"},{"key":"2026072715535552800_cit49","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1039\/C6SC04524C","article-title":"NMR-filtered\nvirtual screening leads to non-metal chelating\nmetallo-\u03b2-lactamase inhibitors","volume":"8","author":"Li","year":"2017","journal-title":"Chem.\nSci"},{"key":"2026072715535552800_cit50","volume-title":"Performance Standards for\nAntimicrobial Susceptibility\nTesting; CLSI Supplement M100","author":"CLSI.","year":"2025","edition":"35th"},{"key":"2026072715535552800_cit51","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.1021\/acs.jmedchem.4c01514","article-title":"Discovering New\nMetallo-Deubiquitinase CSN5 Inhibitors by a Non-Catalytic Activity\nAssay Platform","volume":"67","author":"Yan","year":"2024","journal-title":"J. Med. Chem"},{"key":"2026072715535552800_cit52","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1021\/acs.jmedchem.4c00049","article-title":"X-ray Structure-Guided\nDiscovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That\nShows Activity in a Parkinson\u2019s Disease Mouse Model","volume":"67","author":"Mou","year":"2024","journal-title":"J. Med. Chem"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02230","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/20\/21807\/66291936\/acs.jmedchem.5c02230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/20\/21807\/66291936\/acs.jmedchem.5c02230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:04:25Z","timestamp":1785182665000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/20\/21807\/5234643\/Structural-Optimization-of-Bicyclic-Oxo-Boronates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":52,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10,13]]},"published-print":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02230","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02230.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02230.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02230.s003","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}